Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, mood stabilizers, stimulants, and weight-loss drugs.
Everyday Health on MSN12d
FDA Expands Access to Clozapine for Treatment-Resistant SchizophreniaPatients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results